Navigation Links
BioScrip Reports First Quarter 2013 Financial Results
Date:5/8/2013

the end of the first quarter was zero and outstanding borrowings under its revolving credit facility was approximately $28.0 million as it utilized a combination of its available cash and borrowings under its revolving credit facility to fund the acquisition of HomeChoice.  Subsequent to the end of the first quarter, the Company raised net proceeds of $118.6 million from a public offering of its common stock and used part of such net proceeds to pay down outstanding amounts under its revolving credit facility.

Outlook
The Company reaffirms its initial 2013 revenue target of $830.0 million to $865.0 million and 2013 Adjusted EBITDA target of $67.0 million to $73.0 million.

Conference Call
BioScrip will host a conference call to discuss its first quarter 2013 financial results on May 9, 2013 at 8:30 a.m. Eastern Time.

Interested parties may participate in the conference call by dialing 800-705-5308 (US), or 303-223-4377 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available for two weeks after the call's completion by dialing 800-633-8284 (US) or 402-977-9140 (International) and entering conference call ID number 21656383. An audio webcast and archive will also be available for 30 days under the "Investor Relations" section of the BioScrip website at www.bioscrip.com.

About BioScrip, Inc.
BioScrip, Inc. provides comprehensive infusion and home care solutions. By partnering with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers we are able to provide access to infusible medications and management solutions. Our goal is to optimize outcomes for chronic and other complex healthcare conditions and enhance the quality of patient life. BioScrip brings clinical competence in providing high-touch, comprehensive infusion and nursing services to patients in the most convenient ways possible.
'/>"/>

SOURCE BioScrip, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. BioScrip To Present At "NINE" Noble Financial Capital Markets Ninth Annual Equity Conference
2. China Biologic Reports Financial Results for the First Quarter of 2013
3. Nephros Reports First Quarter 2013 Financial Results
4. PharmAthene Reports First Quarter 2013 Financial And Operational Results
5. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
6. Sangamo BioSciences Reports First Quarter 2013 Financial Results
7. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
8. Halozyme Reports First Quarter 2013 Financial Results
9. Depomed Reports First Quarter 2013 Financial Results
10. InspireMD Reports Financial Results For Period Ended March 31, 2013
11. Isis Reports Financial Results and Highlights for First Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015 According to ... Peripheral Vascular Devices Market (Embolic Protection, Chronic Total ... Grafts, IVC Filters, Stents, Balloons and Accessories) - ... Cardiology and Peripheral Vascular Devices Market is expected ... a CAGR of 7.4% from 2014 to 2019. ...
(Date:6/3/2015)... Conn. , June 3, 2015  SurgiQuest®, ... innovative access technologies for minimally invasive surgery (MIS) ... AirSeal® System in over 250,000 procedures.  Adoption has ... procedures over last year, driven by the company,s ... as well as geographic expansion to over 45 ...
(Date:6/3/2015)... PillPack, the pharmacy that simplifies medication management, today announced ... led by CRV with participation from Accel Partners, Atlas ... be used to fuel growth, accelerate the hiring of ... markets. "In the last two years, we,ve ... folks absolutely love," says TJ Parker, PharmD, CEO of ...
Breaking Medicine Technology:The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4Rapid Procedure Growth With SurgiQuest's AirSeal System 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3
... 15, 2010 Menicon Co., Ltd. has announced its ... for Optimed,s CAPTIV8 communication services and i-Vue content-driven digital ... obtained exclusive distribution rights for Optimed,s products in Japan ... ) "First of all, I would like ...
... PRINCETON, N.J., Nov. 15, 2010 BioWa, Inc. announced ... with Agensys, Inc., an affiliate of Tokyo based Astellas ... ® Technology platform for the purpose of identifying ... "We are extremely pleased about our Agreement with ...
Cached Medicine Technology:Menicon Expands Partnership with Optimed in North America 2BioWa Announces License of POTELLIGENT® Technology to Agensys 2
(Date:6/3/2015)... NC (PRWEB) June 03, 2015 Researchers ... two biomarkers for mesothelioma and say the tried-and-true marker ... just posted an article on the research. Click ... the University’s National Center for Asbestos Related Diseases say, ... positive results, it is still preferable to fibulin-3 for ...
(Date:6/3/2015)... 2015 According to an article published ... intercepted fake oxycodone pills which actually contained the potent ... look legitimate, and even sported the “A/215” imprint common ... consuming 30 mg oxycodone to be exceptionally critical of ... buy them illegally on the street. Fentanyl is an ...
(Date:6/3/2015)... 03, 2015 Fourroux Prosthetics, located at ... will celebrate its grand opening with a ribbon cutting ... prosthetic center of its kind in the area, Fourroux ... care and outcomes through use of patented advanced prosthetics ... CEO of Fourroux Prosthetics, states, “Our goal has always ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 DailyEndorphin is ... "events" programming module. With this highly configurable new ... and report on many components of its wellness programming ... no additional charge. , With this new module, annual ... DE challenges, (2) Create participant surveys, (3) Continually report ...
(Date:6/3/2015)... 2015 On May 29, 2015, Health ... effective immediately, which now permits the use of gluten-free ... as ingredients. The MA is a prelude to an ... should be aware that, unlike the unlimited use of ... are restrictions for gluten-free oat products sold in Canada. ...
Breaking Medicine News(10 mins):Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3
... organizations have called on the medical profession to ... health between Indigenous and non-Indigenous Australians . ... of Australia, Dr Mark Wenitong, President of the ... the National Aboriginal Community Controlled Health Organization and ...
... Indigenous mothers living in remote areas are 14 per cent ... in regional or city areas say Indigenous health researchers ... Womens and Childrens Health at the University of New South ... Welfare National Perinatal Statistics Unit and her colleagues, examined whether ...
... the brain to sensitize people to overreact to an ... people who dont have a stress-related disorder, says new ... have long lasting effects on the brain and behavior ... But these subtle changes could increase susceptibility to mental ...
... the growing epidemic of diabetes in the US is out. ... . ,According to a drug trend report released ... cholesterol medications in total prescription drug spending growth in 2006. ... obesity a leading cause of diabetes are expected ...
... in the mouth like a popular breath-freshener could someday ... The innovative drug-delivery system was developed by Johns ... two-semester course, the seven-student team fabricated a thin film ... the child to swallow the vaccine. The dissolved medication ...
... become one of the first major universities in the country ... University officials intend to give the Fayetteville campus community ... the policy: the ban is scheduled to go into effect ... issue, said Mary Alice Serafini, assistant vice chancellor for student ...
Cached Medicine News:Health News:Trauma Exposure can Affect Brain Function Several Years After Event 2Health News:Spending on Diabetes Drugs Soars in US 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 3Health News:University of Arkansas to Ban Tobacco from Its Campus 2Health News:University of Arkansas to Ban Tobacco from Its Campus 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: